Form 4: Molina Healthcare Director Richard Zoretic Acquires Shares Under Equity Incentive Plan

Director Richard C. Zoretic acquired 168 shares of Molina Healthcare, Inc. common stock on April 1, 2025, as part of the company's 2019 Equity Incentive Plan.

Summary

• Richard C. Zoretic, a director of Molina Healthcare, Inc., acquired 168 shares of common stock on April 1, 2025.
• The acquisition was part of the company's 2019 Equity Incentive Plan and is related to his services as a director.
• The shares were granted at a price of $327.71 per share, based on the closing price of Molina Healthcare's common stock on that day.
• The grant is part of an annual equity award to each director, valued at $220,000, with quarterly grants of $55,000.
• Following the transaction, Zoretic beneficially owns 7,165 shares indirectly through a revocable living trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, indicating a stable and ongoing governance structure. The sentiment is neutral to positive as it reflects standard practice.

Positives

• The equity incentive plan aligns the interests of directors with those of shareholders.
• The quarterly grant schedule provides a consistent stream of equity compensation.
• The director's continued stock ownership demonstrates confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements, but the equity incentive plan suggests a continued commitment to aligning director compensation with company performance.

Industry Context

Equity compensation is a common practice for directors of publicly traded companies to align their interests with those of shareholders. The size and structure of the equity award are typical for companies of Molina Healthcare's size and industry.

Comparison to Industry Standards

• Director compensation packages typically include a mix of cash and equity.
• The specific amount of equity granted to directors varies based on company size, performance, and industry benchmarks.
• Comparing Molina Healthcare's director compensation to peers like UnitedHealth Group, Humana, or Centene would provide a more detailed assessment of its competitiveness.

Stakeholder Impact

• Shareholders may view the equity incentive plan positively as it aligns director interests with company performance.
• The transaction has a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Molina Healthcare, Director, Richard Zoretic, Equity Incentive Plan, Stock Acquisition, Form 4, Beneficial Ownership